The newly launched African Medicines Agency marks a transformative step toward ensuring that drug development, testing and regulation finally reflect the continent’s vast genetic diversity and urgent health needs. Its success could redefine global standards and improve treatments for billions of people of African ancestry.
View the full article here.
Authors:
Investigator in the drug metabolism and pharmacokinetics team at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, South Africa
Professor of organic chemistry and the founder and director of the H3D Centre at the University of Cape Town, South Africa
Professor of human genetics at the Center for Human Genetics and Genomics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda